[HTML][HTML] Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease

DL Bernstein, H Hülkova, MG Bialer, RJ Desnick - Journal of hepatology, 2013 - Elsevier
Cholesteryl ester storage disease (CESD) is caused by deficient lysosomal acid lipase (LAL)
activity, predominantly resulting in cholesteryl ester (CE) accumulation, particularly in the …

Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives

M Solomon, S Muro - Advanced drug delivery reviews, 2017 - Elsevier
Lysosomes and lysosomal enzymes play a central role in numerous cellular processes,
including cellular nutrition, recycling, signaling, defense, and cell death. Genetic deficiencies …

Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1−/− mouse

B Liu, SD Turley, DK Burns, AM Miller… - Proceedings of the …, 2009 - National Acad Sciences
Niemann-Pick type C disease is largely attributable to an inactivating mutation of NPC1
protein, which normally aids movement of unesterified cholesterol (C) from the …

[HTML][HTML] A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2

J Hamilton, I Jones, R Srivastava, P Galloway - Clinica chimica acta, 2012 - Elsevier
BACKGROUND: Cholesterol ester storage disease (CESD) and Wolman Disease (WD) are
due to deficiency of lysosomal acid lipase (LAL). A new method is described for the …

Production of pharmaceutical‐grade recombinant aprotinin and a monoclonal antibody product using plant‐based transient expression systems

GP Pogue, F Vojdani, KE Palmer, E Hiatt… - Plant biotechnology …, 2010 - Wiley Online Library
Plants have been proposed as an attractive alternative for pharmaceutical protein
production to current mammalian or microbial cell‐based systems. Eukaryotic protein …

Lysosomal lipid storage diseases

H Schulze, K Sandhoff - Cold Spring Harbor …, 2011 - cshperspectives.cshlp.org
Lysosomal lipid storage diseases, or lipidoses, are inherited metabolic disorders in which
typically lipids accumulate in cells and tissues. Complex lipids, such as glycosphingolipids …

Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment

A Aqul, B Liu, CM Ramirez, AA Pieper… - Journal of …, 2011 - Soc Neuroscience
While unesterified cholesterol (C) is essential for remodeling neuronal plasma membranes,
its role in certain neurodegenerative disorders remains poorly defined. Uptake of sterol from …

Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology

GA Grabowski, M Golembo, Y Shaaltiel - Molecular genetics and …, 2014 - Elsevier
Gaucher disease (GD) is a rare, genetic lysosomal storage disorder caused by functional
defects of acid β-glucosidase that results in multiple organ dysfunction. Glycosylation of …

δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders

M Xu, K Liu, M Swaroop, FD Porter, R Sidhu… - Journal of Biological …, 2012 - ASBMB
Niemann-Pick disease type C (NPC) and Wolman disease are two members of a family of
storage disorders caused by mutations of genes encoding lysosomal proteins. Deficiency in …

Genetic determinants of hepatic steatosis in man

AJ Hooper, LA Adams, JR Burnett - Journal of lipid research, 2011 - ASBMB
Hepatic steatosis is one of the most common liver disorders in the general population. The
main cause of hepatic steatosis is nonalcoholic fatty liver disease (NAFLD), representing the …